Published in Biophys J on August 01, 1998
Single-channel properties of IKs potassium channels. J Gen Physiol (1998) 1.92
A computational model of the human left-ventricular epicardial myocyte. Biophys J (2004) 1.88
MinK-dependent internalization of the IKs potassium channel. Cardiovasc Res (2009) 1.72
Protein kinase C downregulates I(Ks) by stimulating KCNQ1-KCNE1 potassium channel endocytosis. Heart Rhythm (2011) 1.55
MinK subdomains that mediate modulation of and association with KvLQT1. J Gen Physiol (2000) 1.54
KCNE3 truncation mutants reveal a bipartite modulation of KCNQ1 K+ channels. J Gen Physiol (2004) 1.40
Molecular impact of MinK on the enantiospecific block of I(Ks) by chromanols. Br J Pharmacol (2000) 1.25
The S4-S5 linker of KCNQ1 channels forms a structural scaffold with the S6 segment controlling gate closure. J Biol Chem (2010) 1.19
Tight coupling of rubidium conductance and inactivation in human KCNQ1 potassium channels. J Physiol (2003) 1.15
Differential roles of S6 domain hinges in the gating of KCNQ potassium channels. Biophys J (2005) 1.13
Gating and flickery block differentially affected by rubidium in homomeric KCNQ1 and heteromeric KCNQ1/KCNE1 potassium channels. Biophys J (2000) 1.12
Structural correlates of selectivity and inactivation in potassium channels. Biochim Biophys Acta (2011) 1.04
Regulation of Voltage-Activated K(+) Channel Gating by Transmembrane β Subunits. Front Pharmacol (2012) 1.03
Two open states and rate-limiting gating steps revealed by intracellular Na+ block of human KCNQ1 and KCNQ1/KCNE1 K+ channels. J Physiol (2001) 0.99
An inactivation gate in the selectivity filter of KCNQ1 potassium channels. Biophys J (2007) 0.98
PIP2 regulation of KCNQ channels: biophysical and molecular mechanisms for lipid modulation of voltage-dependent gating. Front Physiol (2014) 0.97
External barium affects the gating of KCNQ1 potassium channels and produces a pore block via two discrete sites. J Gen Physiol (2004) 0.96
Domain-domain interactions determine the gating, permeation, pharmacology, and subunit modulation of the IKs ion channel. Elife (2014) 0.95
Inactivation as a new regulatory mechanism for neuronal Kv7 channels. Biophys J (2007) 0.95
Ionic permeation and conduction properties of neuronal KCNQ2/KCNQ3 potassium channels. Biophys J (2004) 0.95
Modulation of homomeric and heteromeric KCNQ1 channels by external acidification. J Physiol (2002) 0.93
Allosteric features of KCNQ1 gating revealed by alanine scanning mutagenesis. Biophys J (2011) 0.93
The KCNQ1 channel - remarkable flexibility in gating allows for functional versatility. J Physiol (2015) 0.91
Single-channel basis for the slow activation of the repolarizing cardiac potassium current, I(Ks). Proc Natl Acad Sci U S A (2013) 0.90
Voltage-dependent C-type inactivation in a constitutively open K+ channel. Biophys J (2008) 0.89
The KCNE Tango - How KCNE1 Interacts with Kv7.1. Front Pharmacol (2012) 0.89
MinK endows the I(Ks) potassium channel pore with sensitivity to internal tetraethylammonium. Biophys J (2000) 0.87
A kinetic study on the stereospecific inhibition of KCNQ1 and I(Ks) by the chromanol 293B. Br J Pharmacol (2001) 0.87
KCNE1 divides the voltage sensor movement in KCNQ1/KCNE1 channels into two steps. Nat Commun (2014) 0.87
Voltage-Dependent Gating: Novel Insights from KCNQ1 Channels. Biophys J (2016) 0.87
Gating currents from Kv7 channels carrying neuronal hyperexcitability mutations in the voltage-sensing domain. Biophys J (2012) 0.85
KCNE Regulation of K(+) Channel Trafficking - a Sisyphean Task? Front Physiol (2012) 0.85
KCNQ1 channels do not undergo concerted but sequential gating transitions in both the absence and the presence of KCNE1 protein. J Biol Chem (2012) 0.80
KCNQ1 subdomains involved in KCNE modulation revealed by an invertebrate KCNQ1 orthologue. J Gen Physiol (2011) 0.80
Extracellular potassium inhibits Kv7.1 potassium channels by stabilizing an inactivated state. Biophys J (2011) 0.79
Drosophila KCNQ channel displays evolutionarily conserved electrophysiology and pharmacology with mammalian KCNQ channels. PLoS One (2011) 0.78
Reconstruction of Cell Surface Densities of Ion Pumps, Exchangers, and Channels from mRNA Expression, Conductance Kinetics, Whole-Cell Calcium, and Current-Clamp Voltage Recordings, with an Application to Human Uterine Smooth Muscle Cells. PLoS Comput Biol (2016) 0.75
Differential effects of ginsenoside metabolites on slowly activating delayed rectifier K(+) and KCNQ1 K(+) channel currents. J Ginseng Res (2013) 0.75
A complex partnership: KCNQ1 and KCNE1. Biophys J (2013) 0.75
Chlorthalidone inhibits the KvLQT1 potassium current in guinea-pig ventricular myocytes and oocytes from Xenopus laevis. Br J Pharmacol (2007) 0.75
Biophysical and molecular mechanisms of Shaker potassium channel inactivation. Science (1990) 15.75
A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell (1995) 11.62
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell (1995) 10.18
Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature (1996) 9.77
K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature (1996) 8.63
Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels. Receptors Channels (1993) 8.09
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet (1996) 7.35
HERG, a human inward rectifier in the voltage-gated potassium channel family. Science (1995) 7.26
The inward rectification mechanism of the HERG cardiac potassium channel. Nature (1996) 6.29
Modulation of K+ current by frequency and external [K+]: a tale of two inactivation mechanisms. Neuron (1995) 4.62
Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet (1997) 3.90
Fast inactivation causes rectification of the IKr channel. J Gen Physiol (1996) 3.88
A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet (1997) 3.79
Cloning of a membrane protein that induces a slow voltage-gated potassium current. Science (1988) 3.57
Molecular determinants for activation and inactivation of HERG, a human inward rectifier potassium channel. J Physiol (1996) 3.29
The surprising heart: a review of recent progress in cardiac electrophysiology. J Physiol (1984) 3.18
A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes. J Physiol (1997) 2.60
A minK-HERG complex regulates the cardiac potassium current I(Kr). Nature (1997) 2.03
The cardiac hyperpolarizing-activated current, if. Origins and developments. Prog Biophys Mol Biol (1985) 2.02
KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet (1997) 1.90
The conduction pore of a cardiac potassium channel. Nature (1998) 1.86
Molecular mechanism and functional significance of the MinK control of the KvLQT1 channel activity. J Biol Chem (1997) 1.79
KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci U S A (1997) 1.70
Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J (1997) 1.55
Site-specific mutations in a minimal voltage-dependent K+ channel alter ion selectivity and open-channel block. Neuron (1991) 1.53
Pathophysiological mechanisms of dominant and recessive KVLQT1 K+ channel mutations found in inherited cardiac arrhythmias. Hum Mol Genet (1997) 1.48
Time, voltage and ionic concentration dependence of rectification of h-erg expressed in Xenopus oocytes. FEBS Lett (1996) 1.45
Time-dependent outward current in guinea pig ventricular myocytes. Gating kinetics of the delayed rectifier. J Gen Physiol (1990) 1.29
Four novel KVLQT1 and four novel HERG mutations in familial long-QT syndrome. Circulation (1997) 1.15
Ionic current mechanisms generating vertebrate primary cardiac pacemaker activity at the single cell level: an integrative view. Annu Rev Physiol (1992) 1.14
Properties and regulation of the minK potassium channel protein. Physiol Rev (1997) 1.00
The cardiac ion channels: relevance to management of arrhythmias. Annu Rev Med (1996) 0.89
KVLQT1 mutations in three families with familial or sporadic long QT syndrome. Hum Mol Genet (1996) 0.86
The long QT syndrome: a novel missense mutation in the S6 region of the KVLQT1 gene. Hum Genet (1997) 0.85
Structural parts involved in activation and inactivation of the sodium channel. Nature (1989) 8.72
Inhibition of Bax channel-forming activity by Bcl-2. Science (1997) 5.10
Single channel recordings of K+ currents in squid axons. Nature (1980) 4.48
Potassium and sodium ion current noise in the membrane of the squid giant axon. J Physiol (1975) 4.03
Measurement of the conductance of the sodium channel from current fluctuations at the node of Ranvier. J Physiol (1976) 3.46
Mapping the site of block by tetrodotoxin and saxitoxin of sodium channel II. FEBS Lett (1991) 3.29
The steady state properties of ion exchange membranes with fixed sites. Biophys J (1965) 3.23
Subthreshold behavior and phenomenological impedance of the squid giant axon. J Gen Physiol (1970) 3.02
Channel noise in nerve membranes and lipid bilayers. Q Rev Biophys (1975) 2.67
Nonstationary noise analysis and application to patch clamp recordings. Methods Enzymol (1992) 2.60
Pursuing the structure and function of voltage-gated channels. Trends Neurosci (1990) 2.47
Gating currents of inactivating and non-inactivating potassium channels expressed in Xenopus oocytes. Pflugers Arch (1991) 2.28
The muscle chloride channel ClC-1 has a double-barreled appearance that is differentially affected in dominant and recessive myotonia. J Gen Physiol (1999) 2.17
Conductance of the sodium channel in myelinated nerve fibres with modified sodium inactivation. J Physiol (1976) 2.15
The steady-state properties of an ion exchange membrane with mobile sites. Biophys J (1966) 2.09
Conductance fluctuations from the inactivation process of sodium channels in myelinated nerve fibres. J Physiol (1980) 1.75
Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. Clin Genet (2012) 1.72
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant (2009) 1.65
Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndrome. J Med Genet (2006) 1.64
Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies. Eur J Nucl Med Mol Imaging (2009) 1.62
Detection of phospholipid phase separation. A multifrequency phase fluorimetry study of 1,6-diphenyl-1,3,5-hexatriene fluorescence. J Biol Chem (1984) 1.58
Leishmania in SLE mimicking an exacerbation. Clin Exp Rheumatol (2006) 1.54
Disposition of metformin (N,N-dimethylbiguanide) in man. Clin Pharmacol Ther (1978) 1.50
Inward rectifier potassium channels in plants differ from their animal counterparts in response to voltage and channel modulators. Eur Biophys J (1995) 1.42
Structure of the squid axon membrane as derived from charge-pulse relaxation studies in the presence of absorbed lipophilic ions. J Membr Biol (1981) 1.42
Time-resolved fluorescence emission spectra of Laurdan in phospholipid vesicles by multifrequency phase and modulation fluorometry. Cell Mol Biol (1986) 1.41
Evidence for the detrimental role of proteolysis during liver preservation in humans. Gastroenterology (1995) 1.40
Biological activity of chitosan: ultrastructural study. Biomaterials (1988) 1.39
Nerve fiber behaviour in heavy water under voltage-clamp. Biophysik (1968) 1.39
Pressure dependence of sodium gating currents in the squid giant axon. Eur Biophys J (1984) 1.36
Pressure dependence of the potassium currents of squid giant axon. J Membr Biol (1982) 1.31
Non-stationary fluctuations of the potassium conductance at the node of ranvier of the frog. J Physiol (1984) 1.25
Generating diversity at GABAergic synapses. Trends Neurosci (2001) 1.24
Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. J Am Coll Cardiol (2001) 1.24
Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7/11. Clin Genet (2008) 1.21
GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J Neurosci (1995) 1.21
hKChIP2 is a functional modifier of hKv4.3 potassium channels: cloning and expression of a short hKChIP2 splice variant. Cardiovasc Res (2001) 1.20
Mechanism of block of single protopores of the Torpedo chloride channel ClC-0 by 2-(p-chlorophenoxy)butyric acid (CPB). J Gen Physiol (2001) 1.18
Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study. Clin Exp Rheumatol (2004) 1.16
Cardiac involvement in patients with Wegener's granulomatosis. Rheumatol Int (2000) 1.14
Recording of gating currents from Xenopus oocytes and gating noise analysis. Methods Enzymol (1992) 1.13
Nerve membrane electrical characteristics near the resting state. Biophysik (1970) 1.12
Gating and flickery block differentially affected by rubidium in homomeric KCNQ1 and heteromeric KCNQ1/KCNE1 potassium channels. Biophys J (2000) 1.12
Influence of partial hepatectomy on the induction of liver microsomal drug-metabolizing enzymes produced by phenobarbital. A biochemical and ultrastructural study. Lab Invest (1970) 1.12
Heterogeneity of glutamatergic and GABAergic release machinery in cerebral cortex. Neuroscience (2007) 1.12
Potassium and sodium current noise from squid axon membranes. Fed Proc (1975) 1.09
GAT-3, a high-affinity GABA plasma membrane transporter, is localized to astrocytic processes, and it is not confined to the vicinity of GABAergic synapses in the cerebral cortex. J Neurosci (1996) 1.09
The block of Shaker K+ channels by kappa-conotoxin PVIIA is state dependent. J Gen Physiol (1999) 1.09
Relationship between cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol (1997) 1.09
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography. Ultraschall Med (2011) 1.08
A novel D458V mutation in the SANS PDZ binding motif causes atypical Usher syndrome. J Mol Med (Berl) (2005) 1.07
Unmasking Kabuki syndrome. Clin Genet (2012) 1.07
Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas. J Clin Oncol (1998) 1.06
Skewed X inactivation in an X linked nystagmus family resulted from a novel, p.R229G, missense mutation in the FRMD7 gene. Br J Ophthalmol (2007) 1.05
Abl interconnects oncogenic Met and p53 core pathways in cancer cells. Cell Death Differ (2011) 1.05
Pressure dependence of the sodium currents of squid giant axon. J Membr Biol (1982) 1.05
Endogenous expression of the beta1A sodium channel subunit in HEK-293 cells. FEBS Lett (2000) 1.03
Single point mutations of the sodium channel drastically reduce the pore permeability without preventing its gating. Eur Biophys J (1991) 1.03
Voltage noise, current noise and impedance in space clamped squid giant axon. Pflugers Arch (1974) 1.01
Frequencies of gap- and tight-junction mutations in Turkish families with autosomal-recessive non-syndromic hearing loss. Clin Genet (2003) 1.01
Presynaptic NMDA receptors in the neocortex are both auto- and heteroreceptors. Neuroreport (1996) 1.00
Clinical and mutation data in 12 patients with the clinical diagnosis of Nager syndrome. Hum Genet (2013) 1.00
PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain. J Pharmacol Exp Ther (1998) 1.00
Beyond the oncogene paradigm: understanding complexity in cancerogenesis. Acta Biotheor (2008) 1.00
Changes in extrinsic fluorescence in squid axons during voltage-clamp. Science (1970) 1.00
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. Ann Rheum Dis (2002) 0.99
Soybean-protein diet in the treatment of type-II hyperlipoproteinaemia. Lancet (1977) 0.99
A Novel Familial BBS12 Mutation Associated with a Mild Phenotype: Implications for Clinical and Molecular Diagnostic Strategies. Mol Syndromol (2010) 0.99
Metabolic profiling by 13C-NMR spectroscopy: [1,2-13C2]glucose reveals a heterogeneous metabolism in human leukemia T cells. Biochimie (2005) 0.99
Postnatal development of the vesicular GABA transporter in rat cerebral cortex. Neuroscience (2003) 0.99
Heterogeneity of glutamatergic and GABAergic release machinery in cerebral cortex: analysis of synaptogyrin, vesicle-associated membrane protein, and syntaxin. Neuroscience (2009) 0.99
[The pulmonary artery hypertension in patients with sarcoidosis (author's transl)]. G Ital Cardiol (1980) 0.98
Alcohol and viral hepatitis: a mini-review. Dig Liver Dis (2008) 0.97
Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer. Blood (2000) 0.96
The novel R75Q mutation in the GJB2 gene causes autosomal dominant hearing loss and palmoplantar keratoderma in a Turkish family. Clin Genet (2002) 0.96
Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations. J Med Genet (2007) 0.96
The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine. Mol Psychiatry (2001) 0.96
Intracellular magnesium blocks sodium outward currents in a voltage- and dose-dependent manner. Biophys J (1989) 0.95
Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int J Immunopathol Pharmacol (2004) 0.95
A novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency. J Clin Endocrinol Metab (2003) 0.94
Effects of hydrostatic pressure on membrane processes. Sodium channels, calcium channels, and exocytosis. J Gen Physiol (1987) 0.94
Effect of acetyl-L-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat--study by 13P- and 1H-NMR spectroscopy. Brain Res (1994) 0.94
CADASIL syndrome in a large Turkish kindred caused by the R90C mutation in the Notch3 receptor. Eur J Neurol (2002) 0.93
A new syndrome, congenital extraocular muscle fibrosis with ulnar hand anomalies, maps to chromosome 21qter. J Med Genet (2005) 0.93
APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology. Transplant Proc (2009) 0.93
BTNL2 gene variant and sarcoidosis. Thorax (2006) 0.93
IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation. Int J Immunopathol Pharmacol (2012) 0.93
Atherosclerosis: a classic inflammatory disease. Int J Immunopathol Pharmacol (2012) 0.93
Single acetylcholine receptor channel currents recorded at high hydrostatic pressures. Proc Natl Acad Sci U S A (1987) 0.91
Inhibitory effects of cyclosporine on human regulatory T cells in vitro. Transplant Proc (2009) 0.91
IL-32: a newly-discovered proinflammatory cytokine. J Biol Regul Homeost Agents (2009) 0.91
Abscisic acid-induced microheterogeneity in phospholipid vesicles. A fluorescence study. Biophys Chem (1990) 0.90
Entry of [(1,2-13C2)acetyl]-L-carnitine in liver tricarboxylic acid cycle and lipogenesis: a study by 13C NMR spectroscopy in conscious, freely moving rats. Eur J Biochem (1999) 0.90
Reversible electrical breakdown of squid giant axon membrane. Biochim Biophys Acta (1981) 0.90
New radiopharmaceuticals for imaging rheumatoid arthritis. Q J Nucl Med Mol Imaging (2006) 0.90
The callosal connections of the primary somatosensory cortex and the neural bases of midline fusion. Exp Brain Res (1989) 0.89
A new locus for autosomal recessive non-syndromic mental retardation maps to 1p21.1-p13.3. Clin Genet (2007) 0.89
Vascular endothelial growth factor (VEGF), mast cells and inflammation. Int J Immunopathol Pharmacol (2013) 0.89
Nutrition and cancer prevention. Int J Immunopathol Pharmacol (2012) 0.88
220 Mc nuclear magnetic resonance spectra of gramicidin S in solution. Nature (1969) 0.88